Typicality: | 0.392 |
Saliency: | 0.334 |
in august | 5 | temporal |
in the third quarter of 2016 | 4 | temporal |
with planned treatment period | 3 | other |
trial → begin enrolling → patient | 12 |
trial → start enrolling → patient | 7 |
trial → begin enrolling → participant | 5 |
negative | neutral | positive |
0.050 | 0.787 | 0.163 |
Raw frequency | 24 |
Normalized frequency | 0.334 |
Modifier score | 0.500 |
Perplexity | 226.137 |